Ruxolitinib is an effective treatment for CALR‐positive patients with myelofibrosis. (25th August 2015) - Guglielmelli, Paola; Rotunno, Giada; Bogani, Costanza; Mannarelli, Carmela; Giunti, Laura; Provenzano, Aldesia; Giglio, Sabrina; Squires, Matthew; Stalbovskaya, Viktoriya; Gopalakrishna, Prashanth; Vannucchi, Alessandro M.; ,